Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation – a prospective trial

por Burghuber, Christopher K., Kandioler, Daniela, Strobl, Stephanie, Mittlböck, Martina, Böhmig, Georg A., Soliman, Thomas, Berlakovich, Gabriela A.
Publicado 2018

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients

por Kandioler, Daniela, Mittlböck, Martina, Kappel, Sonja, Puhalla, Harald, Herbst, Friedrich, Langner, Cord, Wolf, Brigitte, Tschmelitsch, Jörg, Schippinger, Walter, Steger, Günther, Hofbauer, Friedrich, Samonigg, Hellmut, Gnant, Michael, Teleky, Bela, Kührer, Irene
Publicado 2015

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed—mutation rate of the marker higher than expected

por Kappel-Latif, Sonja, Zacherl, Johannes, Hejna, Michael, Westerhoff, Maria, Tamandl, Dietmar, Ba-Ssalamah, Ahmed, Mittlböck, Martina, Wolf, Brigitte, Wrba, Friedrich, Kührer, Irene, Pluschnig, Ursula, Schoppmann, Sebastian F., Függer, Reinhold, Zwrtek, Ronald, Glaser, Karl, Karner, Josef, Längle, Friedrich, Wenzl, Etienne, Roka, Rudolf, Öfner, Dietmar, Tschmelitsch, Jörg, Hold, Michael, Keil, Felix, Gnant, Michael, Kandioler, Daniela
Publicado 2018